DNAH17 and hepatocellular carcinoma: A total of 186 (51%) of 366 sequenced HCC patients had genetic alteration in dynein axonemal heavy chain genes, and DNAH17 was found to be altered in ten percent of all sequenced patients (Figure 1A); it is one of the top two most frequently altered genes among all DNAH genes.